Cargando…
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
To evaluate the efficacy of atezolizumab plus bevacizumab treatment in patients with hepatocellular carcinoma (HCC) previously treated with molecular targeted agents (MTAs). Thirty-one patients treated with atezolizumab plus bevacizumab for unresectable HCC and previously treated with MTAs were enro...
Autores principales: | Sugimoto, Rie, Satoh, Takeaki, Ueda, Akihiro, Senju, Takeshi, Tanaka, Yuki, Yamashita, Shinsaku, Koyanagi, Toshimasa, Kurashige, Tomoyuki, Higuchi, Nobito, Nakamura, Tsukasa, Tanaka, Masatake, Azuma, Yuuki, Ohno, Akari, Ooho, Aritsune, Ooe, Mari, Mutsuki, Taiji, Uchimura, Koutarou, Kuniyoshi, Masami, Tada, Seiya, Aratake, Yoshifusa, Yoshimoto, Tsuyoshi, Yamashita, Naoki, Harada, Shigeru, Nakamuta, Makoto, Motomura, Kenta, Kohjima, Motoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542563/ https://www.ncbi.nlm.nih.gov/pubmed/36221372 http://dx.doi.org/10.1097/MD.0000000000030871 |
Ejemplares similares
-
Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma
por: Sugimoto, Rie, et al.
Publicado: (2022) -
NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells
por: Kohjima, Motoyuki, et al.
Publicado: (2007) -
Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study
por: Ogawa, Eiichi, et al.
Publicado: (2022) -
Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals
por: Ogawa, Eiichi, et al.
Publicado: (2021) -
A high prevalence of extreme hyperferritinemia in acute hepatitis patients
por: Kotoh, Kazuhiro, et al.
Publicado: (2009)